We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

G1A:XETRGEA Group Aktiengesellschaft Analysis

Data as of 2026-07-24 - not real-time

CHF 50.35

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

GEA Group is trading at CHF 50.35, well below its 20‑day (≈55.9), 50‑day (≈53.1) and 200‑day (≈55.5) simple moving averages, signaling a bearish technical backdrop. The RSI of 78.9 places the stock in overbought territory, while the MACD line sits beneath its signal line, producing a bearish histogram – both pointing to potential downside pressure toward the identified support at CHF 54.10. Volatility remains elevated at roughly 21 % over the past 30 days, yet the beta of –0.15 suggests the share moves independently of broader market swings. Liquidity appears thin, with daily volume reported at only 15 shares, raising concerns about price stability during any rapid moves.
On the fundamentals side, GEA delivers solid profitability with a 7.6 % net margin and a 16.6 % ROE, while growth is modest at 1.2 % YoY. The price‑to‑earnings ratio of 21.2 is notably lower than the industry average of 31.2, indicating relative undervaluation. A dividend yield of 2.11 % is supported by strong operating cash flow (CHF 624 M) and a cash‑to‑debt cushion (CHF 415 M cash vs CHF 251 M debt). Despite a high debt‑to‑equity ratio, the net cash position and stable earnings suggest the dividend is sustainable. Overall, the stock blends defensive cash generation with a value‑oriented valuation, but technical weakness and illiquidity temper short‑term optimism.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Price below all major moving averages
  • Overbought RSI and bearish MACD
  • Thin trading volume increasing downside risk

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • PE well below industry average
  • Strong cash flow covering debt and dividend
  • Stable dividend yield with low payout ratio

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Consistent profitability and solid ROE
  • Diversified exposure to food, beverage and pharma sectors
  • Undervalued valuation coupled with sustainable dividend

Key Metrics & Analysis

Financial Health

Revenue Growth1.20%
Profit Margin7.61%
P/E Ratio21.2
ROE16.65%
ROA6.44%
Debt/Equity9.68
P/B Ratio3.4
Op. Cash FlowCHF624.8M
Free Cash FlowCHF274.8M
Industry P/E31.2

Technical Analysis

TrendNeutral
RSI78.9
SupportCHF 54.10
ResistanceCHF 56.70
MA 20CHF 55.92
MA 50CHF 53.13
MA 200CHF 55.46
MACDBearish
VolumeStable
Fear & Greed Index88.04

Valuation

GradeUndervalued
TypeValue
Dividend Yield2.11%

Risk Assessment

Beta-0.15
Volatility21.16%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.